A Prospective, Two-Staged, Single-Masked Study to Evaluate the Effect of ESBA1008 Applied by Microvolume Injection or Infusion in Subjects With Exudative Age-Related Macular Degeneration

The purpose of this study is to demonstrate a treatment effect of ESBA1008 applied as a microvolume injection or infusion on retinal function and morphology in subjects with exudative age-related macular degeneration (AMD).

本研究旨在证实ESBA1008以微量注射或输注方式给药时，对渗出性年龄相关性黄斑变性（exudative age-related macular degeneration, AMD）受试者的视网膜功能与形态所产生的治疗效果。